Home › NDC Lookup › RxCUI directory › RxCUI 1369756

24 HR loratadine 10 MG / pseudoephedrine sulfate 240 MG Extended Release Oral Tablet [Alle... — RxCUI 1369756

RxNorm drug concept · Semantic branded drug
RxCUI 1369756 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1369756
Official name24 HR loratadine 10 MG / pseudoephedrine sulfate 240 MG Extended Release Oral Tablet [Allerclear]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAllerClear D 10 MG / 240 MG 24HR Extended Release Oral Tablet
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pseudoephedrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves nasal congestion from the common cold, hay fever or other upper respiratory allergies. Many products also relieve sinus congestion and pressure.
  • It depends on the product. Regular tablets and softgels are usually taken every 4 to 6 hours, while 12-hour extended-release tablets are taken every 12 hours. Check your box for th...
  • No. Swallow them whole. Don't divide, crush, chew or dissolve them. Seeing part of the tablet in your stool can happen and is normal.
  • Can I crush or chew the extended-release tablets?
📖 Read our full Pseudoephedrine guide →

🕸️ Concept Web — How 24 HR loratadine 10 MG / pseudoephedrine sulfate... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR loratadine 10 MG / pseudoephedrine sulfate 240 MG Extended Release Oral Tablet [Allerclear] RxCUI 1369756

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Loratadine 28889
    • Pseudoephedrine 8896
    • Loratadine / pseudoephedrine 214682
    • Pseudoephedrine sulfate 91169
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Allerclear 1369748
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Loratadine / pseudoephedrine Extended Release Oral Tablet 668262
    • Loratadine / pseudoephedrine sulfate Extended Release Oral Tablet 2646083
    • Loratadine / pseudoephedrine Oral Product 1165333
    • Loratadine / pseudoephedrine Pill 1165334
    • Loratadine / pseudoephedrine sulfate Oral Product 2661915
    • Loratadine / pseudoephedrine sulfate Pill 2663033
    • Loratadine / pseudoephedrine Extended Release Oral Tablet [Allerclear] 1369750
    • Loratadine / pseudoephedrine sulfate Extended Release Oral Tablet [Allerclear] 2656791
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 24 HR loratadine 10 MG / pseudoephedrine sulfate 240 MG Extended Release Oral Tablet SCD · 1117562
  • Loratadine 10 MG SCDC · 316167
  • Pseudoephedrine sulfate 240 MG SCDC · 1112257
  • Loratadine / pseudoephedrine Extended Release Oral Tablet SCDF · 668262
  • Loratadine / pseudoephedrine sulfate Extended Release Oral Tablet SCDFP · 2646083
  • Loratadine / pseudoephedrine Oral Product SCDG · 1165333
  • Loratadine / pseudoephedrine Pill SCDG · 1165334
  • Loratadine / pseudoephedrine sulfate Oral Product SCDGP · 2661915
  • Loratadine / pseudoephedrine sulfate Pill SCDGP · 2663033

Brand-Name Concepts

  • Loratadine 10 MG / pseudoephedrine sulfate 240 MG [Allerclear] SBDC · 1369755
  • Loratadine / pseudoephedrine Extended Release Oral Tablet [Allerclear] SBDF · 1369750
  • Loratadine / pseudoephedrine sulfate Extended Release Oral Tablet [Allerclear] SBDFP · 2656791
  • Allerclear Oral Product SBDG · 1369751
  • Allerclear Pill SBDG · 1369752
  • Allerclear BN · 1369748

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1369756 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63981-0138-22 15 BLISTER PACK in 1 CARTON (63981-138-22) / 1 TABLET, EXTE... kirkland signature allerclear d 24 hr Costco Wholesale Company 2025-10-03
63981-0724-15 1 BLISTER PACK in 1 CARTON (63981-724-15) / 15 TABLET, EXTE... KIRKLAND SIGNATURE ALLERCLEAR D 24 HR Extended Release Kirkland-COSTCO WHOLESALE COMPANY 2017-08-25
Observed labelers: Costco Wholesale Company (1) · Kirkland-COSTCO WHOLESALE COMPANY (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.